
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.
Business Of Biotech
Advancements in Dermatology and Future Plans
The speakers discuss their collaboration in dermatology, including the approval of a topical Jack inhibitor and their ongoing focus on developing Ruxelletnib cream for various indications, as well as their plans to broaden their scope in treating inflammatory skin disorders and diseases.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.